The diagnostic value of macrophage migration inhibitory factor (MIF) in gastric cancer

Pathology and Oncology Research

Volumn 14, Issue 1, 2008, Pages 79-83

  Camlica, Hakan ^a   Duranyildiz, Derya ^a   Oguz, Hilal ^a   Oral, Ethem Nezih ^a   Yasasever, Vildan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Accuracy; CA 19 9; CEA; Gastric cancer; MIF; Tumor markers

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; MACROPHAGE MIGRATION INHIBITION FACTOR;

ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; MALE; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; CA-19-9 ANTIGEN; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; KAPLAN-MEIERS ESTIMATE; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECEPTORS, CELL SURFACE; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 49349100403     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-008-9002-7     Document Type: Article

References (30)

1. P Correa 1992 Human gastric carcinogenesis: a multistep and multifactorial process Cancer Res 52 6735 6470
2. E Tahara S Semba H Tahara 1996 Molecular biological observations in gastric cancer Semin Oncol 23 307 315
3. Waldman TA, Heberman RH (1982) Tumor markers in diagnosis and in monitoring therapy. In: Holland JF, Frei E (eds) Cancer Medicine. Lea & Febiger, Philadelphia, pp 1068-1089
4. Klavins JV (1985) Tumor markers: clinical and laboratory studies. Alan R. Liss, New York
5. RJ Babaian RP Orlando 1986 Elevated prostatic acid phosphatase: a prognostic factor for stage C adeno carcinoma of prostate J Urol 136 1035 1037
6. HJ Wanebo B Rao CM Pinsky 1978 Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer N Eng J Med 299 448 451
7. R Molina X Filella P Mengual 1990 MCA in patients with breast cancer: correlation with CEA and CA 15.3 Int J Biol Markers 5 14 21
8. JR David 1996 Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction Proc Natl AcadSci USA 56 72 77
9. BR Bloom B Bennett 1996 Mechanism of a reaction in vitro associated with delayed-type hypersensitivity Science 153 80 82
10. J Nishihira 2000 Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth Interferon Cytokine Res 20 751 762
11. K Meyer-Siegler PB Hudon 1996 Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases Urology 48 448 452
12. MT Del Vecchio SA Tripodi F Arcuri 2000 Macrophage migration inhibitory factor in prostatic adenocarcinoma: correlation with tumor grading and combination endocrine treatment related changes Prostate 45 51 57
13. A Kamimura M Kamachi J Nishihira 2000 Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung Cancer 89 334 341
14. M Tomiyasu I Yoshino R Suemitsu 2002 Quantification of macrophage inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance Clin Cancer Res 8 3755 3760
15. T Shimizu R Abe H Nakamura 1999 High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis Biochem Biophys Res Commun 264 751 758
16. ME Pyle M Korbonits M Gueorguiev 2003 Macrophage migration inhibitory factor expression is increased in pituitary adenoma cell nuclei Endocrinol 176 103 110
17. C Munaut J Boniver JM Foidart 2002 Macrophage migration inhibitory factor (MIF) expression inhuman glioblastomas correlates with vascular endothelial growth (VEGF) expression Neurophathol Appl Neurobiol 28 452 460
18. H Bando G Matsumoto M Bando 2002 Expression of macrophage migration inhibitory factor in human breast cancer: association with nodal spread Jpn J Cancer Res 93 389 396
19. SM Akbar M Abe H Murakami 2001 Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis: relevance to pathogenesis Cancer Lett 171 125 132
20. H Legendre C Decaestecker N Nagy 2003 Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers Mod Pathol 16 491 504
21. P Gold SO Freedman 1965 Specific carcinoembryonic antigens of the human digestive system J Exp Med 122 467 481
22. V Yasasever H Camlica EN Oral 1999 Utility of CEA in the Diagnosis of Patients with Cancer J Tumor Marker Oncol 14 1 33 38
23. MJ Duffy 2006 Serum tumor markers in breast cancer: are they of clinical value? Clin Chem 52 345 351
24. H Koprowski Z Steplewski K Mitchell 1979 Colorectal carcinoma antigens detected by hybridoma antibodies Somatic Cell Genet 5 957 972
25. PM Bossuyt JB Reitsma DE Bruns 2004 Towards complete and accurate Reporting of studies of diagnostic accuracy: the STARD initiative Fam Pract 21 4 10
26. Campbell MJ (1999) Medical statistics: a commonsense approach. John Wiley & Sons Inc, Chichester
27. Solberg HE (1986) Textbook of clinical chemistry. W.B. Saunders Company, Lexington, pp 356-409
28. T Shkolnik E Livni R Reshef 1987 Comparison of two lymphokines (macrophage migration inhibition, leukocyte adherence inhibition factors) and carcinoembryonic antigen, in colorectal cancer and colonic premalignant lesions Am J Gastroenterol 82 1275 1278
29. T Shkolnik E Livni R Reshef 1987 The macrophage migration inhibition (MIF) assay as a marker of colorectal cancer. Studies in patients with colorectal cancer, noncolonic neoplasms, and conditions predisposing to colorectal cancer Dis Colon Rectum 30 101 105
30. XX He J Yang YW Ding 2006 Increased epithelial and serum expression of migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis Gut 55 797 802